apitegromab tirzepatide Scholar Rock Q2 2025 slides: nears FDA decision with strong cash position By Scholar Rock Reports Positive Phase – Scholar Rock on X: "Today,

Dual agonists such as tirzepatide activate both GLP-1 and GIP receptors, adding effects on insulin dynamics and fat metabolism

New drugs, especially those with groundbreaking results or unique applications, typically command higher prices due to their novelty and the perceived value they provide

Adapting your skin prep and post-injection care to seasonal conditions is a small detail that matters over long treatment courses

& Hinton, B

After several months at a stable maintenance dose, many people experience sulfur burps rarely or never

Avoid doubling doses to make up for a missed one, as this could increase the risk of side effects